Our findings not only deepen the understanding of lncRNA-mediated transcriptional regulation in CRC but also highlight the CRAT40-YBX1-RelA axis as a potential target for novel anti-metastatic therapies. The gene discussed is YBX1; the disease is colorectal carcinoma.